GSK may sell Horlicks to focus on OTC and oral health

The pharmaceuticals firm will take control of Sensodyne and Panadol from joint venture partner Novartis.

Comments

Popular posts from this blog

Newcastle’s transformation and reconnection testament to Howe’s coaching | Andy Brassell

Finally, in Naija! Weird Japanese Horse Oil cream that erases ugly black spots

Manchester City’s Gabriel Jesus ‘takes it personally’ when he fails in front of goal